Sara Faithfull1, Lauren Turner2, Karen Poole1, Mark Joy1, Ralph Manders3, Jennifer Weprin4, Kerri Winters-Stone4, John Saxton5. 1. School of Health Sciences, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK. 2. Frimley Health NHS Foundation Trust, Frimley, Surrey, UK. 3. Exercise Physiology and Sports Science, University Surrey, Guildford, UK. 4. School of Nursing, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. 5. Department of Sport Exercise and Rehabilitation, Northumbria University, Newcastle Upon Tyne, UK.
Abstract
OBJECTIVE: Prehabilitation is increasingly being used to mitigate treatment-related complications and enhance recovery. An individual's state of health at diagnosis, including obesity, physical fitness and comorbidities, are influencing factors for the occurrence of adverse effects. This review explores whether prehabilitation works in improving health outcomes at or beyond the initial 30 days post-treatment and considers the utility of prehabilitation before cancer treatment. METHODS: A database search was conducted for articles published with prehabilitation as a pre-cancer treatment intervention between 2009 and 2017. Studies with no 30 days post-treatment data were excluded. Outcomes post-prehabilitation were extracted for physical function, nutrition and patient-reported outcomes. RESULTS: Sixteen randomised controlled trials with a combined 2017 participants and six observational studies with 289 participants were included. Prehabilitation interventions provided multi-modality components including exercise, nutrition and psychoeducational aspects. Prehabilitation improved gait, cardiopulmonary function, urinary continence, lung function and mood 30 days post-treatment but was not consistent across studies. CONCLUSION: When combined with rehabilitation, greater benefits were seen in 30-day gait and physical functioning compared to prehabilitation alone. Large-scale randomised studies are required to translate what is already known from feasibility studies to improve overall health and increase long-term cancer patient outcomes.
OBJECTIVE: Prehabilitation is increasingly being used to mitigate treatment-related complications and enhance recovery. An individual's state of health at diagnosis, including obesity, physical fitness and comorbidities, are influencing factors for the occurrence of adverse effects. This review explores whether prehabilitation works in improving health outcomes at or beyond the initial 30 days post-treatment and considers the utility of prehabilitation before cancer treatment. METHODS: A database search was conducted for articles published with prehabilitation as a pre-cancer treatment intervention between 2009 and 2017. Studies with no 30 days post-treatment data were excluded. Outcomes post-prehabilitation were extracted for physical function, nutrition and patient-reported outcomes. RESULTS: Sixteen randomised controlled trials with a combined 2017 participants and six observational studies with 289 participants were included. Prehabilitation interventions provided multi-modality components including exercise, nutrition and psychoeducational aspects. Prehabilitation improved gait, cardiopulmonary function, urinary continence, lung function and mood 30 days post-treatment but was not consistent across studies. CONCLUSION: When combined with rehabilitation, greater benefits were seen in 30-day gait and physical functioning compared to prehabilitation alone. Large-scale randomised studies are required to translate what is already known from feasibility studies to improve overall health and increase long-term cancerpatient outcomes.
Authors: Daniel Santa Mina; Daniel Sellers; Darren Au; Shabbir M H Alibhai; Hance Clarke; Brian H Cuthbertson; Gail Darling; Alaa El Danab; Anand Govindarajan; Karim Ladha; Andrew G Matthew; Stuart McCluskey; Karen A Ng; Fayez Quereshy; Keyvan Karkouti; Ian M Randall Journal: Front Oncol Date: 2021-03-10 Impact factor: 6.244
Authors: Amy M Dennett; Bernadette Zappa; Rachel Wong; Stephen B Ting; Kimberley Williams; Casey L Peiris Journal: Support Care Cancer Date: 2021-05-08 Impact factor: 3.603
Authors: Malcolm A West; Zachos Anastasiou; Gareth Ambler; Lisa Loughney; Michael G Mythen; Thomas Owen; Gerard Danjoux; Denny Z H Levett; Peter M A Calverley; Jamie J Kelly; Sandy Jack; Michael P W Grocott Journal: NIHR Open Res Date: 2021-06-16
Authors: Stéphanie M L M Looijaard; Miriam L Te Lintel Hekkert; Rob C I Wüst; René H J Otten; Carel G M Meskers; Andrea B Maier Journal: Acta Physiol (Oxf) Date: 2020-07-24 Impact factor: 6.311
Authors: Garry Alan Tew; Robin Bedford; Esther Carr; James William Durrand; Joanne Gray; Rhiannon Hackett; Scott Lloyd; Sarah Peacock; Sarah Taylor; David Yates; Gerard Danjoux Journal: BMJ Open Qual Date: 2020-03